ChartRow logo
Data provided bySource: Twelve Data
PeersADMTSNDARCFNTRPR
Share this page

BG financial statements

The full income statement, balance sheet, and cash-flow statement for Bunge Limited (BG), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.

Financial overview#

Revenue

5Y CAGR +11.2%10Y CAGR +4.9%YoY +7.4%
$93.5B TTM$23.8B Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Gross profit

5Y CAGR +4.1%10Y CAGR +2.4%YoY +25.3%
$4.8B TTM$1.3B Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Net income

5Y CAGR −6.6%10Y CAGR +0.3%YoY +91.6%
$1.2B TTM$318M Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

EPS (diluted)

5Y CAGR −8.6%10Y CAGR −0.3%YoY +95.2%
$5.95 TTM$1.64 Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Operating cash flow

5Y n/m10Y CAGR +3.3%YoY n/m
−$955M TTM−$1.2B Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Capital expenditure

5Y CAGR +36.4%10Y CAGR +10.3%YoY −18.1%
$1.7B TTM$384M Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Free cash flow

5Y n/m10Y n/mYoY n/m
−$2.7B TTM−$1.6B Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Shares (diluted)

5Y +11.2%10Y +9.3%YoY −2.2%
195.2M TTM194M Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Dividend per share

5Y CAGR +7.0%10Y CAGR +6.7%YoY −74.3%
$2.88 TTM$0.72 Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Every BG chart on Trends →

Shares outstanding (point-in-time)

2024-09 139.6M2024-12 134.0M2025-03 134.4M2025-06 135.6M2025-09 193.4M2025-12 193.5M2026-03 194.0M2026-06 192.1M2026-09 192.1M+37.6% over 8 periods

SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.

PeriodRangeOrderChangeFiguresAs-reported fiscal years.
Line itemTrendFY2025FY2024FY2023FY2022FY2021
Income Statementas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Revenue70.3B+32.4%53.1B-10.8%59.5B-11.4%67.2B+13.7%59.2B+42.9%
3.41B+0.5%3.39B-30.0%4.84B+31.6%3.68B+9.5%3.36B+20.8%
Cost of revenue66.9B+34.6%49.7B-9.1%54.7B-13.9%63.5B+13.9%55.8B+44.5%
Research & development28.0M-6.7%30.0M-14.3%35.0M+6.1%33.0M+0.0%33.0M+37.5%
Selling, general & administrative2.11B+19.0%1.78B+3.6%1.72B+25.3%1.37B+10.9%1.23B-9.1%
Amortization of intangibles47.0M+27.0%37.0M-39.3%61.0M+48.8%41.0M-14.6%48.0M-2.0%
Provision for credit losses74.0M+45.1%51.0M-28.2%71.0M+7.6%66.0M+88.6%35.0M-45.3%
Interest expense628M+33.3%471M-8.7%516M+28.0%403M+65.8%243M-8.3%
Other non-operating income289M-34.6%442M+242.6%129M+1533.3%-9.00M-101.8%509M+304.0%
Equity-method income26.0M+236.8%-19.0M-112.1%157M+48.1%106M-33.8%160M
Pre-tax income1.13B-25.6%1.52B-50.0%3.05B+47.7%2.07B-19.5%2.56B+81.5%
Income tax288M-14.3%336M-52.9%714M+84.0%388M-2.5%398M+60.5%
816M-28.2%1.14B-49.3%2.24B+39.3%1.61B-22.5%2.08B+81.5%
Income from continuing operations819M-28.0%1.14B-49.3%2.24B——
Discontinued operations-3.00M0.000.00——
Net income to non-controlling interest27.0M-47.1%51.0M-45.7%94.0M+38.2%68.0M-23.6%89.0M+345.0%
Net income to common816M-28.2%1.14B-49.3%2.24B+39.3%1.61B-21.2%2.04B+82.3%
$4.91-38.5%$7.99-46.3%$14.87+41.5%$10.51-22.9%$13.64+76.9%
EPS (basic)$4.95-38.8%$8.09-46.3%$15.07+39.2%$10.83-25.3%$14.50+81.9%
Weighted-avg shares (basic)165M+17.4%141M-5.6%149M+0.1%149M+5.5%141M+0.2%
Weighted-avg shares (diluted)166M+17.0%142M-5.7%151M-1.5%153M+0.5%152M+1.8%
Dividends per share$2.80+2.9%$2.72+4.1%$2.61+8.9%$2.40+15.4%$2.08+4.0%
Balance Sheetas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
24.4B+52.8%16.0B-2.4%16.4B-2.4%16.8B+1.8%16.5B+1.7%
Cash & equivalents1.14B-65.7%3.31B+27.2%2.60B+135.7%1.10B+22.4%902M+156.3%
Short-term investments861M+77.9%484M+361.0%105M-11.8%119M-77.1%520M+50.3%
Accounts receivable3.87B+80.2%2.15B-17.1%2.59B-8.4%2.83B+33.9%2.11B+23.0%
Inventory13.2B+103.3%6.49B-8.6%7.11B-15.5%8.41B-0.3%8.43B+17.6%
Prepaid expenses342M+108.5%164M-52.6%346M-8.0%376M-1.1%380M+64.5%
Other current assets5.79B+44.7%4.00B-1.3%4.05B-7.5%4.38B-7.8%4.75B-24.2%
44.5B+78.8%24.9B-1.9%25.4B+3.2%24.6B+3.2%23.8B+0.7%
Property, plant & equipment—5.25B+15.7%4.54B+25.5%3.62B+3.4%3.50B-7.3%
Operating lease right-of-use1.69B+80.9%932M+0.6%926M-9.6%1.02B+12.3%912M+5.1%
Goodwill3.14B+593.4%453M-7.4%489M+4.0%470M-2.9%484M-17.4%
Intangible assets309M-3.7%321M-19.3%398M+10.6%360M-16.5%431M-18.5%
Long-term investments136M-21.8%174M+22.5%142M-12.9%163M-16.8%196M+44.1%
Deferred tax assets890M+38.0%645M-16.6%773M+8.6%712M+29.5%550M+62.2%
Other non-current assets938M+68.4%557M-9.4%615M-1.9%627M-12.8%719M-3.6%
15.1B+103.5%7.43B-3.3%7.69B-19.9%9.60B+3.0%9.32B-15.1%
Accounts payable4.88B+75.8%2.78B-24.2%3.66B-16.5%4.39B+3.2%4.25B+61.2%
Accrued liabilities1.39B+65.5%840M-2.9%865M+14.6%755M+9.6%689M+5.7%
Deferred revenue814M+62.5%501M+8.2%463M-23.0%601M+37.5%437M+7.6%
Short-term & current debt5.22B+238.1%1.54B+92.5%802M-42.4%1.39B+18.3%1.18B-58.5%
Current lease liability499M+74.5%286M-7.1%308M-27.5%425M+21.4%350M+48.9%
Other current liabilities4.26B+51.1%2.82B-3.3%2.91B-13.8%3.38B-1.3%3.42B-29.2%
Finance lease liability (current)23.0M+228.6%7.00M+133.3%3.00M+200.0%1.00M—
27.1B+94.3%13.9B+2.9%13.6B-7.3%14.6B-6.4%15.6B-8.3%
Long-term debt8.83B+88.1%4.69B+15.0%4.08B+25.2%3.26B-31.9%4.79B+7.5%
Non-current lease liability1.10B+84.4%595M+5.1%566M+3.5%547M+8.1%506M-12.9%
Operating lease liability (total)1.60B+81.2%881M+0.8%874M-10.1%972M+13.6%856M+4.9%
Finance lease liability (total)180M+106.9%87.0M+45.0%60.0M+252.9%17.0M—
Finance lease liability157M+96.3%80.0M+40.4%57.0M+256.3%16.0M—
Deferred tax liabilities988M+160.7%379M-5.3%400M+9.6%365M+8.0%338M-6.1%
Other non-current liabilities1.06B+25.5%847M+2.8%824M-2.9%849M+29.0%658M+0.2%
15.9B+60.4%9.91B-8.6%10.9B+17.6%9.22B+20.3%7.67B+26.4%
Preferred stock———0.00-100.0%690M+0.0%
Common stock——0.00-100.0%1.00M+0.0%1.00M+0.0%
Additional paid-in capital9.84B+84.8%5.33B-9.7%5.90B-11.8%6.69B+19.7%5.59B+3.4%
Retained earnings13.2B+2.4%12.8B+6.3%12.1B+18.1%10.2B+13.8%8.98B+24.1%
Treasury stock1.01B-35.0%1.55B+44.4%1.07B-18.7%1.32B+17.9%1.12B+9.8%
Accumulated other comprehensive income-6.08B+9.2%-6.70B-10.7%-6.05B+5.0%-6.37B+1.5%-6.47B-3.6%
Non-controlling interest1.47B+42.0%1.03B+7.2%963M+31.6%732M+369.2%156M+14.7%
Total equity incl. non-controlling17.4B+58.7%10.9B-7.4%11.8B+18.7%9.96B+27.2%7.83B+26.1%
Total liabilities & equity44.5B+78.8%24.9B-1.9%25.4B+3.2%24.6B+3.2%23.8B+0.7%
Common shares issued———150M+6.3%141M+0.9%
Common shares outstanding———150M+6.3%141M+0.9%
Shares outstanding (cover)194M+44.4%134M-6.6%143M-4.3%150M+6.1%141M+0.8%
Treasury shares15.1M-29.2%21.3M+32.3%16.1M-14.5%18.8M+12.6%16.7M+8.4%
Cash Flowas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
844M-55.6%1.90B-42.6%3.31B+159.6%-5.55B-91.7%-2.89B+18.2%
Depreciation & amortization703M+50.2%468M+3.8%451M+10.5%408M-3.8%424M-2.5%
Intangible amortization47.0M+27.0%37.0M-39.3%61.0M+48.8%41.0M-14.6%48.0M-2.0%
Deferred income taxes-62.0M-520.0%-10.0M-900.0%-1.00M+99.2%-119M+56.3%-272M-483.1%
Change in receivables469M+377.5%-169M+34.0%-256M-224.3%206M-61.1%530M+107.8%
Change in inventory700M+829.2%-96.0M+93.7%-1.52B-664.3%269M-79.3%1.30B-43.4%
-5.23B-369.2%-1.11B-10.4%-1.01B-115.5%6.50B+27.1%5.11B+182.0%
Capital expenditure1.72B+25.2%1.38B+22.6%1.12B+102.2%555M+39.1%399M+9.3%
Free cash flow-879M-267.7%524M-76.0%2.19B+135.8%-6.10B-85.4%-3.29B+15.6%
Acquisitions4.20B0.000.00——
Proceeds from sale of PP&E953M+11812.5%8.00M-95.3%170M-66.5%508M-21.5%647M+233.5%
Other investing activities-43.0M-150.0%86.0M+213.2%-76.0M-181.7%93.0M+472.0%-25.0M-13.6%
2.23B+2576.7%-90.0M+89.5%-856M-11.3%-769M+52.9%-1.63B-192.6%
Long-term debt issued3.60B+76.1%2.04B+102.9%1.01B+236.0%300M-70.0%1.00B-58.3%
Long-term debt repaid2.37B+214.7%753M-36.0%1.18B+14.3%1.03B+25625.0%4.00M-99.8%
Common stock issued0.000.000.000.000.00
Common stock repurchased551M-49.9%1.10B+83.3%600M+200.0%200M+100.0%100M+0.0%
Dividends paid459M+21.4%378M-1.3%383M+9.7%349M+20.8%289M+2.5%
Other financing activities-45.0M+21.1%-57.0M-14.0%-50.0M+0.0%-50.0M-900.0%-5.00M+50.0%
FX effect on cash
————-63.0M-431.6%
Net change in cash-2.16B-406.7%705M-52.1%1.47B+495.5%247M-52.9%524M+788.1%
Interest paid562M+29.5%434M-14.4%507M+25.8%403M+41.4%285M+8.0%
Income taxes paid186M-64.2%520M-20.6%655M+14.9%570M+7.3%531M+279.3%
Valuation Ratiosas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Market cap17.2B+65.5%10.4B-29.0%14.7B-1.9%14.9B+13.5%13.2B+43.7%
P/E21.1×+130.6%9.2×+22.6%7.5×-24.8%9.9×+56.7%6.3×-20.8%
P/S0.2×+25.0%0.2×-18.1%0.2×+7.7%0.2×-0.2%0.2×+0.5%
P/B1.1×+3.1%1.1×-26.6%1.4×-16.7%1.7×-0.0%1.7×+13.7%
P/FCF—19.9×-54.6%43.8×——
Earnings yield4.7%-56.6%10.9%-18.5%13.4%+32.9%10.1%-36.2%15.8%+26.3%
FCF yield—5.0%+120.2%2.3%——
Dividend yield3.1%-10.1%3.5%+35.2%2.6%+7.6%2.4%+8.0%2.2%-26.9%
Source filing10-K10-K10-K10-K10-K

One company, more than one SEC registrant: these statements were filed by Bungeltd until Nov 1, 2023 and by Bunge Global Sa since.

Fiscal yearCEOTotal, as reportedActually paidOther executives, average$100 in the stock$100 in peers
FY2025—$18.9M$24.5M$7.7M$155.00$101.00
FY2024—$16.8M$1.9M$4.6M$131.00$108.00
FY2023—$17.6M$18.4M$4.7M$165.00$118.00
FY2022—$17.9M$36.9M$5M$159.00$130.00
FY2021—$16.1M$53.4M$6.5M$146.00$115.00
FY2020—$12.5M$36M$5.9M——

From the pay-versus-performance table of each proxy statement (DEF 14A), the newest that states the year. “Actually paid” values stock awards at the year’s closing price, so it falls when the stock does. A year two chief executives shared lists each one’s pay, as reported / actually paid, and the totals are both. $100 in the stock and in the peer group the proxy names are the newest proxy’s, from the start of its first year.

About this data

Source: BG’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all BG filings on SEC EDGAR → Not investment advice.